Novartis unit Alcon picks up Tear Film Innovations

Novartis (NYSE:NVS) subsidiary Alcon said it acquired Tear Film Innovations for an undisclosed amount.

San Diego-based TFI makes the iLux system, which is designed to treat blocked meibomian glands in eyelids.